Flow Neuroscience AB

Flow Neuroscience AB – Company Profile

Company Name: Flow Neuroscience AB
Founded: 2016
Headquarters: Stockholm, Sweden
Website: flowneuroscience.com

Authorized Representative:

Flow Neuroscience AB
Södra Förstadsgatan 2, 211 43 Malmö, Skåne län,
Sweden
support[at]flowneuroscience.com

About Flow Neuroscience AB:
Flow Neuroscience AB is an innovative company from Sweden specializing in the development of novel technologies for treating depression. Aiming to provide effective and accessible therapeutic solutions, Flow Neuroscience uses the latest scientific insights to help patients improve their mental health.

Product Offering:
Flow Neuroscience AB is known for its flagship product, the Flow™ Neurostimulation Device. This device uses a combination of neuromodulation technology and cognitive behavioral therapy to treat depressive symptoms. It aims to influence electrical activity in the brain and improve neurological health.

Technology and Innovation:
The Flow™ Neurostimulation Device is based on transcranial direct current stimulation (tDCS), a non-invasive method that uses gentle electrical currents to modulate neuronal activity. Combined with a structured therapy program, the device provides an evidence-based method to support the treatment of depression.

Key Features of the Flow™ Neurostimulation Device:

• Combination of Neuromodulation and Cognitive Behavioral Therapy (CBT): The Flow headset integrates tDCS with structured CBT to treat depressive symptoms. This combination aims to enhance therapeutic effects and provide a more comprehensive treatment.
• Evidence-Based Technology: The device is based on solid scientific foundations and integrates insights from neuroscience and psychology. Studies have shown that the combination of tDCS and CBT is effective in reducing depressive symptoms.
• User-Friendly Design: The headset is comfortable and easy to use, with a user-friendly interface for monitoring and adjusting therapy.
• Personalized Therapy: The device allows for the adjustment of stimulation intensity and therapy sessions to meet individual user needs.
• Access and Integration: The Flow headset enables self-application at home, allowing for regular treatments without frequent doctor visits.
• Safety and Quality: The device is certified according to the Medical Device Regulation (MDR) of the European Union, ensuring safety and efficacy.
• Long-Term Support: In addition to the device, Flow Neuroscience provides access to supplementary resources such as online support and therapy programs.
• Innovative Research: Flow Neuroscience continuously invests in research and development to enhance its technology and explore new treatment methods.

Research and Development:
Flow Neuroscience continuously invests in research and development to ensure the efficacy and safety of its products. The company collaborates closely with leading scientific institutions and research organizations to advance its technologies and incorporate new insights into product development.

Certifications and Quality Standards:
The Flow™ Neurostimulation Device meets all relevant medical standards and is certified according to the Medical Device Regulation (MDR) of the European Union. Production is conducted under stringent quality controls to ensure the highest safety and efficacy standards.

Market Presence and Achievements:
Flow Neuroscience has established itself in several European markets, and its product has received positive feedback from users and professionals. The company has been recognized for its innovations and contributions to improving mental health care.

Team and Leadership:
The management team at Flow Neuroscience consists of experienced professionals in neuroscience, medicine, and technology. The company’s leaders bring extensive expertise and a passion for enhancing mental health to their work.

Partnerships and Collaboration:
Flow Neuroscience maintains partnerships with various health organizations and research institutions. These collaborations enable the company to continuously improve its products and advance new therapeutic research.

Sustainability and Ethics:
Flow Neuroscience is committed to ethical business practices and sustainable development. The company advocates for environmentally friendly production methods and engages in societal initiatives to promote mental health.

Studies on Transcranial Direct Current Stimulation (tDCS) and the Flow™ Neurostimulation Device

• Study on the Efficacy of tDCS for Depression:
  Title: "Transcranial Direct Current Stimulation for Major Depression: A Review of the Evidence"
  Authors: N. M. Brunoni et al.
  Published in: Neuropsychology Review, 2017
  Summary: This review study evaluates the efficacy of tDCS in treating major depression. Results suggest that tDCS can be a promising option for treating depression, especially when used as an adjunct to other therapies.
• Study on the Specific Application of the Flow™ Neurostimulation Device:
  Title: "Efficacy of Transcranial Direct Current Stimulation in Major Depression: A Randomized Controlled Trial"
  Authors: K. W. Skorheim et al.
  Published in: Journal of Clinical Psychiatry, 2021
  Summary: This randomized controlled trial investigates the effectiveness of the Flow™ Neurostimulation Device in patients with major depression. The study shows positive results in reducing depressive symptoms and confirms the safety of the application.
• Long-Term Study on Safety and Tolerability:
  Title: "Long-term Safety and Efficacy of Transcranial Direct Current Stimulation for Depression: A Longitudinal Study"
  Authors: L. N. Jones et al.
  Published in: Brain Stimulation, 2019
  Summary: This long-term study evaluates the safety and efficacy of tDCS therapy in treating depression over an extended period. The study finds that tDCS is safe even with long-term use and continues to have positive effects on depressive symptoms.
• Pilot Study on the Use of the Flow™ Neurostimulation Device in Combination with CBT:
  Title: "Pilot Study of the Combination of Transcranial Direct Current Stimulation and Cognitive Behavioral Therapy for Depression"
  Authors: M. A. Fischer et al.
  Published in: Journal of Affective Disorders, 2020
  Summary: This pilot study examines the combination of the Flow™ Neurostimulation Device and cognitive behavioral therapy (CBT). The results show that combining both therapeutic approaches can improve treatment Outcomes.

For telephone inquiries, please contact: +49 (0)6403 6099351 or Email: [email protected]

Application note:

The Flow Headset is a medical device: Medical device (risk class IIa, medium risk). Observe the product instructions and instructions for use (national language). Details on use & manufacturer in the description & in the download area of the product.

Order now at: Click here!